Skip to content
value.today

VolitionRx Ltd.

Total raised
$5 M
3 rounds on record
Latest round
$1 M
Sep 2014
First round on record
Apr 2012
Today
Went public
See the company page

VolitionRx Ltd. is listed today as VolitionRx Limited: market value, financials and filings are on its company page.

Funding rounds

3 counted as startup funding, 3 other private sales on record. Open the number of investors for the round's details.

Funding rounds of VolitionRx Ltd.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2025$23 MPrivate placement after listing$10 to $50 million

VolitionRx Ltd.: Private sale, May 2025

Investors in this round

1 investor had bought by the notice of Jan 28, 2026: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $23 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Common Stock issuable upon conversion of Warrants and Senior Secured Convertible Promissory Notes
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cameron Reynolds · Executive Officer, Director
  • Gael Thomas Forterre · Executive Officer
  • Gaetan Thomas Michel · Executive Officer
  • Jacob Thomas Micallef · Executive Officer
  • Jasmine Thomas Kway · Executive Officer
  • Louise Batchelor · Executive Officer
  • Nicholas Thomas Plummer · Executive Officer
  • Rodney Rootsaert · Executive Officer
  • Salvatore Thomas Butera · Executive Officer
  • Terig Hughes · Executive Officer
  • Alan Thomas Colman · Director
  • Ethel I Rubin · Director
  • Guy Archibald Innes · Director
  • Kim Archibald Nguyen · Director
  • Mickie Thomas Henshall · Director
  • Phillip Archibald Barnes · Director
  • Timothy I Still · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The Total Offering Amount consists of two separate closings including $6,400,000 in the additional closing held in January 2026 and assumes full exercise of the issued Warrants.”

Signed by Cameron Reynolds, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 28, 2026. Read the notice at the SEC.

debt, optionsSEC
Aug 2018$24 MPrivate placement after listing$10 to $50 million

VolitionRx Ltd.: Private sale, Aug 2018

Investors in this round

1 investor had bought by the notice of Aug 27, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$24 M of $24 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, other: Common Stock; Warrants Convertible into Common Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cameron Reynolds · Executive Officer, Director · President, Chief Executive Officer and Director
  • David Cecil Vanston · Executive Officer · Chief Financial Officer
  • Jacob Archibald Micallef · Executive Officer · Chief Scientific Officer
  • Jason Archibald Terrell · Executive Officer · Chief Medical Officer
  • Rodney Cecil Rootsaert · Executive Officer · Secretary
  • Alan Archibald Colman · Director
  • Edward Archibald Futcher · Director
  • Guy Archibald Innes · Director
  • Habib Archibald Skaff · Director
  • Martin Charles Faulkes · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes $9,000,000 from sale of Common Stock and up to $15,000,000 from future conversion of Warrants into Common Stock”

Signed by Cameron Reynolds, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 27, 2018. Read the notice at the SEC.

equity, optionsSEC
Sep 2014$1 MNo. 3Under $2 million

VolitionRx Ltd.: Raise no. 3, Sep 2014

Investors in this round

7 investors had bought by the notice of Sep 25, 2014: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$59,906
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cameron Reynolds · Executive Officer, Director · President, Chief Executive Officer & Director
  • Mike O'Connell · Executive Officer · Chief Financial Officer & Treasurer
  • Rodney Gerard Rootsaert · Executive Officer · Secretary
  • Alan Archibold Colman · Director
  • Guy Archibold Innes · Director
  • Habib Archibold Skaff · Director
  • Martin Gerard Faulkes · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • "Founding Asset Management (""FAM"")" (CRD 122282) · London, United KingdomSold in NH

Remarks in the notice

  • On fees: “The $59,906 commission was calculated as 7% of the total investment from those certain investors introduced by FAM. Pursuant to a Settlement Agreement, the commission owed was converted into 27,230 shares of common stock.”

Signed by Cameron Reynolds, President, Chief Executive Officer & Director. Source: SEC Form D, newest notice filed Sep 25, 2014. Read the notice at the SEC.

equitySEC
Feb 2014$3 MNo. 2$2 to $10 million

VolitionRx Ltd.: Raise no. 2, Feb 2014

Investors in this round

24 investors had bought by the notice of Mar 11, 2014: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$160,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cameron Reynolds · Executive Officer, Director
  • Malcolm Lewin · Executive Officer
  • Rodney Gerard Rootsaert · Executive Officer
  • Alan Archibald Colman · Director
  • Guy Archibald Innes · Director
  • Martin Gerard Faulkes · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Founding Asset Management (CRD 122282) · London, United KingdomSold in CT, WA
  • Lake Street Capital Markets (CRD 164447) · Minneapolis, MinnesotaSold in CA, CO, CT, FL, IL, MA, MD, MN, MT, NC, NJ, NY, OH, PA, WA
  • MZ Advisory Pte Ltd · Singapore, SingaporeSold in no state named, and outside the US

Signed by Cameron Reynolds, Pres, ceo, director. Source: SEC Form D, newest notice filed Mar 11, 2014. Read the notice at the SEC.

equity, optionsSEC
Apr 2012$1 MNo. 1Under $2 million

VolitionRx Ltd.: Raise no. 1, Apr 2012

Investors in this round

33 investors had bought by the notice of Jul 26, 2012: 33 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
$52,483
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cameron Reynolds · Executive Officer, Director · PRESIDENT, CEO, DIRECTOR
  • Malcolm Lewin · Executive Officer · CFO, TREASURER
  • Rodney Rootsaert · Executive Officer · SECRETARY
  • Alan Colman · Director
  • Guy Innes · Director
  • Martin Faulkes · Director
  • Satu Vainikka · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • ANDREWS SECURITIES LLC (CRD 36402) · Denver, ColoradoSold in CA, CO, FL, IL

Signed by Cameron Reynolds, President, ceo, director. Source: SEC Form D, newest notice filed Jul 26, 2012. Read the notice at the SEC.

equity, optionsSEC
Oct 2011$2 MIssued in a merger or acquisitionUnder $2 million

VolitionRx Ltd.: Private sale, Oct 2011

Investors in this round

38 investors had bought by the notice of Oct 28, 2011: 38 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cameron Reynolds · Executive Officer, Director · President, Chief Executive Officer and Director
  • Malcolm Lewin · Executive Officer · Chief Financial Officer and Treasurer
  • Rodney Gerard Rootsaert · Executive Officer · Secretary
  • Alan Archibald Colman · Director
  • Guy Archibald Innes · Director
  • Kevin John Alexander · Director
  • Martin Gerard Faulkes · Director
  • Satu Gerard Vainikka · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “The offering is being made in connection with that certain Share Purchase Agreement dated September 26, 2011 which closed on October 6, 2011.”

Signed by Cameron Reynolds, President, Chief Executive Officer and Director. Source: SEC Form D, newest notice filed Oct 28, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • VolitionRx Ltd. chose not to state its revenue in its newest notice of a funding round (Jan 2026).

    SEC Form D · Jan 2026

  • Revenue range over time, as stated in its notices: no revenue in 2011; revenue of up to $1 million in 2012.

    SEC Form D (revenue range) · Jul 2012

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2026

Products and services#

No products or services of VolitionRx Ltd. are on record.

Investors#

No investor of VolitionRx Ltd. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 33 investors.

Largest shareholders today

Institutions holding VolitionRx Limited shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by VolitionRx Ltd.
NameRoleNamed in
Cameron ReynoldsExecutive officerJan 2026
Gael Thomas ForterreExecutive officerJan 2026
Gaetan Thomas MichelExecutive officerJan 2026
Jacob Thomas MicallefExecutive officerJan 2026
Jasmine Thomas KwayExecutive officerJan 2026
Louise BatchelorExecutive officerJan 2026
Nicholas Thomas PlummerExecutive officerJan 2026
Rodney RootsaertExecutive officerJan 2026
Salvatore Thomas ButeraExecutive officerJan 2026
Terig HughesExecutive officerJan 2026
David Cecil VanstonChief Financial OfficerAug 2018
Jacob Archibald MicallefChief Scientific OfficerAug 2018
Jason Archibald TerrellChief Medical OfficerAug 2018
Rodney Cecil RootsaertSecretaryAug 2018
Mike O'ConnellChief Financial Officer & TreasurerSep 2014
Rodney Gerard RootsaertSecretarySep 2014
Malcolm LewinExecutive officerMar 2014
Alan Thomas ColmanDirectorJan 2026
Cameron ReynoldsDirectorJan 2026
Ethel I RubinDirectorJan 2026
Guy Archibald InnesDirectorJan 2026
Kim Archibald NguyenDirectorJan 2026
Mickie Thomas HenshallDirectorJan 2026
Phillip Archibald BarnesDirectorJan 2026
Timothy I StillDirectorJan 2026
Alan Archibald ColmanDirectorAug 2018
Edward Archibald FutcherDirectorAug 2018
Habib Archibald SkaffDirectorAug 2018
Martin Charles FaulkesDirectorAug 2018
Alan Archibold ColmanDirectorSep 2014
Guy Archibold InnesDirectorSep 2014
Habib Archibold SkaffDirectorSep 2014
Martin Gerard FaulkesDirectorSep 2014
Alan ColmanDirectorJul 2012
Guy InnesDirectorJul 2012
Martin FaulkesDirectorJul 2012
Satu VainikkaDirectorJul 2012
Kevin John AlexanderDirectorOct 2011
Satu Gerard VainikkaDirectorOct 2011

Went public since 2015. Its SEC number is that of a company listed on a stock exchange.